The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Purchase

21 Dec 2020 07:00

Arix Bioscience PLC (ARIX) Director Share Purchase 21-Dec-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc

Director Share Purchase

 

LONDON, 21 December 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Naseem Amin, Executive Chairman, purchased 183,000 ordinary shares ("Ordinary Shares") in the Company on 18 December 2020 at a price of 206p per share, via a corporate entity in which he has a majority beneficial interest.

 

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the transaction in number of Ordinary Shares.

 

 PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Naseem Amin

2

Reason for the notification

a)

Position / status

Executive Chairman

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Purchase of Ordinary Shares by Davum Capital Limited, a corporate entity in which Naseem Amin has a majority beneficial interest

c)

Price(s) and volume(s)

Price(s)

Volume(s)

206.00p

183,000

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

18 December 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

For further information:

 

Robert Lyne Chief Operating Officer and General Counsel +44 (0)207 290 1050

 

 

 - Ends -


ISIN:GB00BD045071
Category Code:DSH
TIDM:ARIX
LEI Code:213800OVT3AHQCXNIX43
Sequence No.:90018
EQS News ID:1156507
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st Oct 20217:00 amEQSTotal Voting Rights
30th Sep 20215:30 pmEQSTransaction in own shares
29th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20215:30 pmEQSTransaction in own shares
28th Sep 20218:16 amEQSArtios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215
27th Sep 20215:30 pmEQSTransaction in own shares
24th Sep 20215:30 pmEQSTransaction in own shares
23rd Sep 20215:30 pmEQSTransaction in own shares
22nd Sep 20215:30 pmEQSTransaction in own shares
21st Sep 20216:00 pmEQSTransaction in own shares
20th Sep 20215:30 pmEQSTransaction in own shares
17th Sep 20215:30 pmEQSTransaction in own shares
16th Sep 20216:00 pmEQSTransaction in own shares
15th Sep 20215:30 pmEQSTransaction in own shares
14th Sep 20215:30 pmRNSTransaction in own shares
13th Sep 20215:30 pmEQSTransaction in own shares
10th Sep 20215:30 pmEQSTransaction in own shares
9th Sep 20215:30 pmEQSTransaction in own shares
8th Sep 20215:30 pmEQSTransaction in own shares
7th Sep 20215:30 pmEQSTransaction in own shares
3rd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 20215:30 pmEQSTransaction in own shares
2nd Sep 202111:21 amEQSArix Bioscience participates in $90 million Series B financing for Disc Medicine
1st Sep 20215:30 pmEQSTransaction in own shares
1st Sep 20217:00 amEQSTotal Voting Rights
31st Aug 20215:30 pmEQSTransaction in own shares
27th Aug 20215:30 pmEQSTransaction in own shares
26th Aug 20215:30 pmEQSTransaction in own shares
25th Aug 20215:30 pmEQSTransaction in own shares
24th Aug 20215:30 pmEQSTransaction in own shares
23rd Aug 20215:30 pmEQSTransaction in own shares
20th Aug 20215:30 pmEQSTransaction in own shares
19th Aug 20215:15 pmEQSTransaction in own shares
18th Aug 20215:30 pmEQSTransaction in own shares
17th Aug 20215:45 pmEQSTransaction in own shares
16th Aug 20215:30 pmEQSTransaction in own shares
16th Aug 20217:00 amEQSDirector/PDMR Shareholding
13th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20215:30 pmEQSTransaction in own shares
12th Aug 20217:01 amEQSInterim Results for the Six Months Ended 30 June 2021
11th Aug 20215:30 pmEQSTransaction in own shares
10th Aug 20215:30 pmEQSTransaction in own shares
9th Aug 20215:30 pmEQSTransaction in own shares
6th Aug 20215:30 pmEQSTransaction in own shares
5th Aug 20215:15 pmEQSTransaction in own shares
4th Aug 20215:28 pmEQSTransaction in own shares
3rd Aug 20215:20 pmEQSTransaction in own shares
2nd Aug 20215:25 pmEQSTransaction in own shares
2nd Aug 20217:00 amEQSTotal Voting Rights
30th Jul 20215:15 pmEQSTransaction in own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.